{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:37:08Z","timestamp":1789468628672,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.yexcr.2025.114425","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T16:27:31Z","timestamp":1736785651000},"page":"114425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["OTUB1 mediates PARP1 deubiquitination to alleviate NAFLD by regulating HMGB1"],"prefix":"10.1016","volume":"445","author":[{"given":"Shuhua","family":"Ai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanli","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenfen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunjun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2025.114425_bib1","article-title":"Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)","volume":"13","author":"Rong","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.yexcr.2025.114425_bib2","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.yexcr.2025.114425_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3920196","article-title":"The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD)","volume":"2020","author":"Tanase","year":"2020","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.yexcr.2025.114425_bib4","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqaa134","article-title":"NAFLD and NASH in postmenopausal women: implications for diagnosis and treatment","volume":"161","author":"DiStefano","year":"2020","journal-title":"Endocrinology"},{"key":"10.1016\/j.yexcr.2025.114425_bib5","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1080\/17461391.2019.1571114","article-title":"Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): roles of oxidative stress and inflammation","volume":"19","author":"Farzanegi","year":"2019","journal-title":"Eur. J. Sport Sci."},{"key":"10.1016\/j.yexcr.2025.114425_bib6","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/s41418-021-00752-9","article-title":"OTUB1 prevents lethal hepatocyte necroptosis through stabilization of c-IAP1 during murine liver inflammation","volume":"28","author":"Koschel","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.yexcr.2025.114425_bib7","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s13402-023-00913-7","article-title":"OTUB1 accelerates hepatocellular carcinoma by stabilizing RACK1 via its non-canonical ubiquitination","volume":"47","author":"Peng","year":"2024","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.yexcr.2025.114425_bib8","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/nature10911","article-title":"The mechanism of OTUB1-mediated inhibition of ubiquitination","volume":"483","author":"Wiener","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2025.114425_bib9","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1038\/ncomms3519","article-title":"OTUB1 enhances TGF\u03b2 signalling by inhibiting the ubiquitylation and degradation of active SMAD2\/3","volume":"4","author":"Herhaus","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2025.114425_bib10","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ymthe.2019.11.027","article-title":"AAV1.SERCA2a gene therapy reverses pulmonary fibrosis by blocking the STAT3\/FOXM1 pathway and promoting the SNON\/SKI Axis","volume":"28","author":"Bisserier","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yexcr.2025.114425_bib11","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/hep.32179","article-title":"OTUB1 alleviates NASH through inhibition of the TRAF6-ASK1 signaling pathways","volume":"75","author":"Zhang","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.yexcr.2025.114425_bib12","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/ijc.33918","article-title":"PARP mediated DNA damage response, genomic stability and immune responses","volume":"150","author":"Zong","year":"2022","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yexcr.2025.114425_bib13","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/hep.26763","article-title":"Poly (ADP-ribose) polymerase-1 is a key mediator of liver inflammation and fibrosis","volume":"59","author":"Mukhopadhyay","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.yexcr.2025.114425_bib14","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jhep.2016.11.020","article-title":"PARP1-mediated PPAR\u03b1 poly(ADP-ribosyl)ation suppresses fatty acid oxidation in non-alcoholic fatty liver disease","volume":"66","author":"Huang","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.yexcr.2025.114425_bib15","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.cmet.2022.03.010","article-title":"SREBP1c-PARP1 axis tunes anti-senescence activity of adipocytes and ameliorates metabolic imbalance in obesity","volume":"34","author":"Lee","year":"2022","journal-title":"Cell Metabol."},{"key":"10.1016\/j.yexcr.2025.114425_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102141","article-title":"Deacetylation-dependent regulation of PARP1 by SIRT2 dictates ubiquitination of PARP1 in oxidative stress-induced vascular injury","volume":"47","author":"Zhang","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.yexcr.2025.114425_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155769","article-title":"Ubiquitination of cytoplasmic HMGB1 by RNF186 regulates hepatic lipophagy in non-alcoholic fatty liver disease","volume":"152","author":"Du","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.yexcr.2025.114425_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg9055","article-title":"Nuclear HMGB1 protects from nonalcoholic fatty liver disease through negative regulation of liver X receptor","volume":"8","author":"Personnaz","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.yexcr.2025.114425_bib19","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41401-018-0044-4","article-title":"PARP1 interacts with HMGB1 and promotes its nuclear export in pathological myocardial hypertrophy","volume":"40","author":"Li","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.yexcr.2025.114425_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24087096","article-title":"PARP1 activation induces HMGB1 secretion promoting intestinal inflammation in mice and human intestinal organoids","volume":"24","author":"Vitali","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2025.114425_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031536","article-title":"The deubiquitinase OTUB1 is a key regulator of energy metabolism","volume":"23","author":"Ruiz-Serrano","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2025.114425_bib22","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/abbs\/gmx056","article-title":"Expression of OTUB1 in hepatocellular carcinoma and its effects on HCC cell migration and invasion","volume":"49","author":"Ni","year":"2017","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.yexcr.2025.114425_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117348","article-title":"Research progress of the Otubains subfamily in hepatocellular carcinoma","volume":"179","author":"Wu","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.yexcr.2025.114425_bib24","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1038\/s41418-020-00700-z","article-title":"Deubiquitinating enzyme OTUB1 promotes cancer cell immunosuppression via preventing ER-associated degradation of immune checkpoint protein PD-L1","volume":"28","author":"Zhu","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.yexcr.2025.114425_bib25","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41392-023-01354-2","article-title":"OTUB1 promotes osteoblastic bone formation through stabilizing FGFR2","volume":"8","author":"Zhu","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.yexcr.2025.114425_bib26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41419-022-04708-w","article-title":"Mesenchymal stem cells protect against ferroptosis via exosome-mediated stabilization of SLC7A11 in acute liver injury","volume":"13","author":"Lin","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexcr.2025.114425_bib27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41388-022-02537-x","article-title":"CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1","volume":"42","author":"Li","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2025.114425_bib28","article-title":"Danlou tablet alleviates sepsis-induced acute lung and kidney injury by inhibiting the PARP1\/HMGB1 pathway","volume":"10","author":"Yu","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.yexcr.2025.114425_bib29","doi-asserted-by":"crossref","first-page":"8244","DOI":"10.1111\/jcmm.16738","article-title":"CircTLK1 modulates sepsis-induced cardiomyocyte apoptosis via enhancing PARP1\/HMGB1 axis-mediated mitochondrial DNA damage by sponging miR-17-5p","volume":"25","author":"Qiu","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.yexcr.2025.114425_bib30","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4161\/15548627.2014.994400","article-title":"Poly-ADP-ribosylation of HMGB1 regulates TNFSF10\/TRAIL resistance through autophagy","volume":"11","author":"Yang","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.yexcr.2025.114425_bib31","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/s41573-020-0076-6","article-title":"Poly(ADP-ribose) polymerase inhibition: past, present and future","volume":"19","author":"Curtin","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.yexcr.2025.114425_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2020.152026","article-title":"Roles of protein ubiquitination in inflammatory bowel disease","volume":"225","author":"Xiao","year":"2020","journal-title":"Immunobiology"},{"key":"10.1016\/j.yexcr.2025.114425_bib33","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.drudis.2021.04.029","article-title":"Small molecules targeting ubiquitination to control inflammatory diseases","volume":"26","author":"Li","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.yexcr.2025.114425_bib34","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41418-020-00708-5","article-title":"Ubiquitination in the regulation of inflammatory cell death and cancer","volume":"28","author":"Cockram","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.yexcr.2025.114425_bib35","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.tig.2020.12.005","article-title":"Histone ubiquitination: an integrative signaling platform in genome stability","volume":"37","author":"Mattiroli","year":"2021","journal-title":"Trends Genet."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482725000217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482725000217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T08:37:53Z","timestamp":1740386273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482725000217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0014482725000217"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2025.114425","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"OTUB1 mediates PARP1 deubiquitination to alleviate NAFLD by regulating HMGB1","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2025.114425","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114425"}}